Source: Annual Congress 2004 - Noninfectious pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. N. Chhajed, M. Dickenmann, L. Bubendorf, M. Mayr, J. Steiger, M. Tamm (Basel, Switzerland). Patterns of pulmonary complications associated with sirolimus. Eur Respir J 2004; 24: Suppl. 48, 3158

Member's Comments

No comment yet.

Related content which might interest you: Predictors of poor outcome in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Factors associated with thromboembolic events in patients with pulmonary tuberculosis Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Uncommon pulmonary complications of inhaled cannabinoide Source: Eur Respir J 2004; 24: Suppl. 48, 537s Year: 2004 Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension Source: Eur Respir J, 50 (4) 1700465; 10.1183/13993003.00465-2017 Year: 2017 Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis Source: Eur Respir J, 54 (6) 1901188; 10.1183/13993003.01188-2019 Year: 2019 Improved survival in medically-treated chronic thromboembolic pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Factors related with complications in patients with pulmonary embolism Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Acute haemodynamic effects of adaptive servoventilation therapy in patients with pulmonary arterial hypertension and patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 Pulmonary hypertension associated with ponatinib therapy Source: Eur Respir J 2016; 47: 676-679 Year: 2016 Chronic thrombo-embolic pulmonary hypertension: Long-term outcomes in operated and non-operated patients Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017 Year: 2017 Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease Source: Annual Congress 2004 - Treatment of pulmonary hypertension Year: 2004 Predictors of physical activity in pulmonary arterial and chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019 High incidence of bacteraemia complicating iv prostaglandin therapy in patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002 Perioperative pulmonary complications and management of patients with COPD and esophageal malignancy Source: Annual Congress 2011 - COPD management Year: 2011 Management of post-transplant airway complications Source: School Course 2012 - Lung Transplantation Year: 2012